Solventum Analyst Price Targets - Benzinga

Solventum Corp

SOLVNYSE

Trade with Public

Trade with Public

$88.03

0.180.2%

마지막 업데이트: Oct 5, 4:00 PM

$88.03

0.180.2%

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 비교 옵션 주식 보고서

Solventum Analyst Price Targets - Benzinga

Solventum Analyst Price Targets

Wall Street analyst price targets and consensus rating for Solventum (SOLV).

Price Target Range — 10 Quarters

Analyst Consensus — 15 Analysts

9Buy

4Hold

2Sell

Consensus RatingOverweight# Analysts15Avg. Consensus PT$89Upside to Avg. PT+1.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 14, 2026	BTIG	Ryan Zimmerman	Maintained	Buy	$95
Aug 6, 2026	UBS	Kevin Caliendo	PT Raise	Buy	$95→$101
Aug 6, 2026	Piper Sandler	Jason Bednar	PT Raise	Overweight	$92→$105
Aug 6, 2026	Wedbush	Michael Piccolo	PT Raise	Outperform	$94→$101
Aug 6, 2026	Keybanc	Brett Fishbin	PT Raise	Overweight	$93→$102
Aug 6, 2026	Stifel	Rick Wise	PT Raise	Buy	$90→$100
Aug 6, 2026	BTIG	Ryan Zimmerman	PT Raise	Buy	$91→$95
Jul 28, 2026	UBS	Kevin Caliendo	Upgrade	Neutral→Buy	$95
Jul 9, 2026	BMO Capital	—	Initiate	Market Perform	$81
May 15, 2026	Wedbush	Michael Piccolo	Initiate	Outperform	$94
May 6, 2026	UBS	Kevin Caliendo	PT Cut	Neutral	$82→$78
May 6, 2026	Stifel	Rick Wise	PT Cut	Buy	$105→$90
May 6, 2026	Wells Fargo	Larry Biegelsen	PT Cut	Equal-Weight	$83→$70
May 6, 2026	Keybanc	Brett Fishbin	PT Raise	Overweight	$92→$93
May 6, 2026	BTIG	Ryan Zimmerman	Maintained	Buy	$89
Apr 27, 2026	Keybanc	Brett Fishbin	PT Cut	Overweight	$99→$92
Apr 17, 2026	Piper Sandler	Jason Bednar	PT Cut	Overweight	$98→$92
Mar 24, 2026	Rothschild & Co	Jackson Philips	Initiate	Sell	$60
Feb 27, 2026	Wells Fargo	Vik Chopra	PT Cut	Equal-Weight	$86→$83
Feb 27, 2026	Keybanc	Brett Fishbin	PT Raise	Overweight	$97→$99

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
BTIG Reiterates Buy on Solventum, Maintains $95 Price Target

BTIG analyst Ryan Zimmerman reiterates Solventum (NYSE:SOLV) with a Buy and maintains $95 price target.

Benzinga Newsdesk

PRO
UBS Maintains Buy on Solventum, Raises Price Target to $101

UBS analyst Kevin Caliendo maintains Solventum (NYSE:SOLV) with a Buy and raises the price target from $95 to $101.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Overweight on Solventum, Raises Price Target to $105

Piper Sandler analyst Jason Bednar maintains Solventum (NYSE:SOLV) with a Overweight and raises the price target from $92 to $105.

Benzinga Newsdesk

PRO
Wedbush Maintains Outperform on Solventum, Raises Price Target to $101

Wedbush analyst Michael Piccolo maintains Solventum (NYSE:SOLV) with a Outperform and raises the price target from $94 to $101.

Benzinga Newsdesk

PRO
Keybanc Maintains Overweight on Solventum, Raises Price Target to $102

Keybanc analyst Brett Fishbin maintains Solventum (NYSE:SOLV) with a Overweight and raises the price target from $93 to $102.

Benzinga Newsdesk

PRO
Stifel Maintains Buy on Solventum, Raises Price Target to $100

Stifel analyst Rick Wise maintains Solventum (NYSE:SOLV) with a Buy and raises the price target from $90 to $100.

Benzinga Newsdesk